Urinary glycosaminoglycan excretion in systemic sclerosis subsets compared with normal controls.

Area of Science:

• Biochemistry
• Rheumatology
• Nephrology

Background:

• Systemic sclerosis is a complex autoimmune disease.
• Glycosaminoglycans (GAGs) play roles in connective tissue structure and repair.
• Altered GAG metabolism may be implicated in systemic sclerosis pathogenesis.

Purpose of the Study:

• To investigate urinary glycosaminoglycan (GAG) excretion in patients with systemic sclerosis.
• To compare GAG excretion between systemic sclerosis subtypes and healthy controls.

Main Methods:

• Quantitative analysis of urinary GAGs.
• Comparison of excretion levels between 30 systemic sclerosis patients and 30 normal controls.
• Subgroup analysis based on disease classification (incomplete CREST vs. diffuse disease).

Main Results:

• No significant difference in overall urinary GAG excretion between the systemic sclerosis group and controls.
• Significantly lower urinary GAG excretion was observed in patients with incomplete CREST syndrome compared to those with diffuse disease.
• Incomplete CREST patients also exhibited lower urinary GAG levels than normal controls.

Conclusions:

• Urinary GAG excretion patterns may differ among systemic sclerosis subtypes.
• Reduced urinary GAG levels in incomplete CREST warrant further investigation into their pathogenetic role.
• GAG metabolism could serve as a potential biomarker in specific systemic sclerosis phenotypes.